EUVIMEDEUVIMED entdecken
Crossref

Eliminating METTL1‐mediated accumulation of PMN‐MDSCs prevents hepatocellular carcinoma recurrence after radiofrequency ablation

Xuezhen Zeng, Guanrui Liao, Shumin Li, Haining Liu, Xiao Zhao, Shuang Li, Kai Lei, Shenghua Zhu, Zhihang Chen, Yi Zhao, Xuxin Ren, Tianhong Su und 6 weitere

Hepatology · 2023-04 · 77 (4) · 1122-1138

DOI: 10.1002/hep.32585 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hepatology, online erschienen am 08.07.2022. Verfasst von Xuezhen Zeng und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Liver Surgery , Center of Hepato-Pancreato-Biliary Surgery , The First Affiliated Hospital, Sun Yat-sen University , Guangzhou , Guangd…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Myeloid-Derived Suppressor Cells, Liver Neoplasms. Die Arbeit wurde bisher 168-mal zitiert (Crossref) und nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims: Radiofrequency ablation (RFA) is an important curative therapy in hepatocellular carcinoma (HCC), but recurrence rate remains as high as all the other HCC therapeutic modalities. Methyltransferase 1 (METTL1), an enzyme for m 7 G tRNA modification, was reported to promote HCC development. Here, we assessed the role of METTL1 in shaping the immunosuppressive tumor microenvironment after insufficient RFA (iRFA). Approach and Results: By immunohistochemistry and multiplex immunofluorescence (mIF) staining, we showed that METTL1 expression was enhanced in post‐RFA recurrent HCC, accompanied by increased CD11b + CD15 + polymorphonuclear‐myeloid–derived suppressor cells (PMN‐MDSCs) and decreased CD8 + T cells. Mechanistically, heat‐mediated METTL1 upregulation enhanced TGF‐β2 translation to form the immunosuppressive environment by induction of myeloid‐derived suppressor cell. Liver‐specific overexpression or knockdown of Mettl1 significantly affected the accumulation of PMN‐MDSCs and subsequently affected CD8 + T cell infiltration. Complete RFA successfully eliminated the tumor, whereas iRFA‐treated mice exhibited enhanced tumor growth and metastasis with increased PMN‐MDSC accumulation and decreased CD8 + T cells compared to sham surgery. Interrupting METTL1‐TGF‐β2‐PMN‐MDSC axis by anti‐Ly6G antibody, or knockdown of hepatoma‐intrinsic Mettl1 or Tgfb2 , or TGF‐β signaling blockade significantly mitigated tumor progression induced by iRFA and restored CD8 + T cell population. Conclusions: Our study sheds light on the pivotal role of METTL1 in modulating an immunosuppressive microenvironment and demonstrated that interrupting METTL1‐TGF‐β2‐PMN‐MDSC axis could be a therapeutic strategy to restore antitumor immunity and prevent HCC recurrence after RFA treatment, meriting further clinical studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularMyeloid-Derived Suppressor CellsLiver NeoplasmsMiceAnimalsTransforming Growth Factor beta2Tumor Microenvironment

Substanzen

Transforming Growth Factor beta2

Autor:innen und Institutionen

  • Department of Liver Surgery , Center of Hepato-Pancreato-Biliary Surgery , The First Affiliated Hospital, Sun Yat-sen University , Guangzhou , Guangdong Province , China.
  • Institute of Precision Medicine , the First Affiliated Hospital , Sun Yat-sen University , Guangzhou , Guangdong Province , China.
  • Department of Gastroenterology and Hepatology , The First Affiliated Hospital, Sun Yat-sen University , Guangzhou , Guangdong Province , China.
  • Department of Oncology , The First Affiliated Hospital of Sun Yat-sen University , Guangzhou , Guangdong Province , China.
  • School of Biomedical Sciences , The Chinese University of Hong Kong , Hong Kong , China.
  • Clinical Trials Unit , The First Affiliated Hospital , Sun Yat-sen University , Guangzhou , Guangdong Province , China.

ORCID-Profile: Ming Kuang

Zitieren

APA

Zeng, X., Liao, G., Li, S., Liu, H., Zhao, X., Li, S., Lei, K., Zhu, S., Chen, Z., Zhao, Y., Ren, X., Su, T., Cheng, A. S., Peng, S., Lin, S., Wang, J., Chen, S., & Kuang, M. (2023). Eliminating METTL1‐mediated accumulation of PMN‐MDSCs prevents hepatocellular carcinoma recurrence after radiofrequency ablation. Hepatology, 77(4), 1122-1138. https://doi.org/10.1002/hep.32585

Vancouver

Zeng X, Liao G, Li S, Liu H, Zhao X, Li S, et al. Eliminating METTL1‐mediated accumulation of PMN‐MDSCs prevents hepatocellular carcinoma recurrence after radiofrequency ablation. Hepatology. 2023;77(4):1122-1138. doi:10.1002/hep.32585

BibTeX
@article{Zeng2023,
  author = {Zeng, Xuezhen and Liao, Guanrui and Li, Shumin and Liu, Haining and Zhao, Xiao and Li, Shuang and Lei, Kai and Zhu, Shenghua and Chen, Zhihang and Zhao, Yi and Ren, Xuxin and Su, Tianhong and Cheng, Alfred Sze-Lok and Peng, Sui and Lin, Shuibin and Wang, Ji and Chen, Shuling and Kuang, Ming},
  title = {Eliminating METTL1‐mediated accumulation of PMN‐MDSCs prevents hepatocellular carcinoma recurrence after radiofrequency ablation},
  journal = {Hepatology},
  year = {2023},
  volume = {77},
  number = {4},
  pages = {1122--1138},
  doi = {10.1002/hep.32585}
}
Kostenlos starten →